Race for coronavirus treatment

Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.

The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.

The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.

It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.

The trial is due to start next week.

Last local news

Monaco Updates - 22nd April

This week, find out more about the Historic Monaco Grand Prix.  Monaco Updates - 22nd April Read More

22/04/2021

Several products recalled by French supermarkets

Several French supermarkets have recalled several pasta, rice, prawns and couscous products for health reasons.... Several products recalled by French supermarkets Read More

22/04/2021

French and Riviera News Thursday 22nd April 2021

French Prime Minister Jean Castex is to hold a press conference this evening at 6pm to outline the gradual lifting of restrictions as planned by the g... French and Riviera News Thursday 22nd April 2021 Read More

22/04/2021

Evening Update Wednesday 21st April 2021

With just over two weeks left of confinement, plans are being put in place to slowly re-open the Cote d’Azur and the country as a whole. From the begi... Evening Update Wednesday 21st April 2021 Read More

21/04/2021